$MGLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MAGELLAN HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MAGELLAN HEALTH INC. Get notifications about new insider transactions in MAGELLAN HEALTH INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 99.05 | 22,875 | 2,265,698 | 13,457 | 36.3 K to 13.5 K (-62.96 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 68.50 | 5,295 | 362,708 | 36,332 | 31 K to 36.3 K (+17.06 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 64.87 | 5,042 | 327,075 | 31,037 | 26 K to 31 K (+19.40 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 63.95 | 12,538 | 801,805 | 25,995 | 13.5 K to 26 K (+93.17 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 68.50 | 6,641 | 454,909 | 13,282 | |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 64.87 | 7,307 | 474,005 | 7,306 | |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 63.95 | 1,480 | 94,646 | 0 | |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 99.04 | 15,428 | 1,527,968 | 0 | 15.4 K to 0 (-100.00 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 68.50 | 6,641 | 454,909 | 15,428 | 8.8 K to 15.4 K (+75.58 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 64.87 | 7,307 | 474,005 | 8,787 | 1.5 K to 8.8 K (+493.72 %) |
| Mar 06 2018 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 63.95 | 1,480 | 94,646 | 1,480 | 0 to 1.5 K |
| Mar 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Option Exercise | M | 0.00 | 2,534 | 0 | 0 | |
| Mar 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Payment of Exercise | F | 100.30 | 1,065 | 106,820 | 30,901 | 32 K to 30.9 K (-3.33 %) |
| Mar 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Buy | M | 0.00 | 2,534 | 0 | 31,966 | 29.4 K to 32 K (+8.61 %) |
| Mar 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Option Exercise | X | 51.79 | 13,375 | 692,691 | 280,875 | |
| Mar 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Sell | S | 101.20 | 13,375 | 1,353,497 | 29,432 | 42.8 K to 29.4 K (-31.24 %) |
| Mar 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Buy | X | 51.79 | 13,375 | 692,691 | 42,807 | 29.4 K to 42.8 K (+45.44 %) |
| Feb 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Option Exercise | X | 51.79 | 13,375 | 692,691 | 294,250 | |
| Feb 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Sell | S | 99.20 | 13,375 | 1,326,765 | 29,432 | 42.8 K to 29.4 K (-31.24 %) |
| Feb 02 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Buy | X | 51.79 | 13,375 | 692,691 | 42,807 | 29.4 K to 42.8 K (+45.44 %) |
| Jan 04 2018 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Option Exercise | X | 53.72 | 30,086 | 1,616,220 | 23,764 | |
| Jan 04 2018 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Sell | S | 96.16 | 30,086 | 2,893,028 | 26,447 | 56.5 K to 26.4 K (-53.22 %) |
| Jan 04 2018 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Buy | X | 53.72 | 30,086 | 1,616,220 | 56,533 | 26.4 K to 56.5 K (+113.76 %) |
| Jan 03 2018 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Option Exercise | X | 53.72 | 17,443 | 937,038 | 53,850 | |
| Jan 03 2018 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Sell | S | 96.07 | 17,443 | 1,675,782 | 26,447 | 43.9 K to 26.4 K (-39.74 %) |
| Jan 03 2018 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Buy | X | 53.72 | 17,443 | 937,038 | 43,890 | 26.4 K to 43.9 K (+65.95 %) |
| Jan 03 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Option Exercise | X | 51.79 | 13,367 | 692,277 | 307,625 | |
| Jan 03 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Sell | S | 95.94 | 13,367 | 1,282,429 | 29,432 | 42.8 K to 29.4 K (-31.23 %) |
| Jan 03 2018 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Buy | X | 51.79 | 13,367 | 692,277 | 42,799 | 29.4 K to 42.8 K (+45.42 %) |
| Dec 06 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 71.00 | 2,180 | 154,780 | 1,666 | |
| Dec 06 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 92.00 | 2,180 | 200,560 | 0 | 2.2 K to 0 (-100.00 %) |
| Dec 06 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 71.00 | 2,180 | 154,780 | 2,180 | 0 to 2.2 K |
| Dec 05 2017 | MGLN | MAGELLAN HEALTH IN ... | Lewis Clapper Caskie | Chief Human Resourc ... | Option Exercise | X | 60.39 | 29,239 | 1,765,743 | 0 | |
| Dec 05 2017 | MGLN | MAGELLAN HEALTH IN ... | Lewis Clapper Caskie | Chief Human Resourc ... | Option Exercise | X | 53.00 | 30,074 | 1,593,922 | 0 | |
| Dec 05 2017 | MGLN | MAGELLAN HEALTH IN ... | Lewis Clapper Caskie | Chief Human Resourc ... | Sell | S | 93.99 | 59,313 | 5,574,586 | 18,400 | 77.7 K to 18.4 K (-76.32 %) |
| Dec 05 2017 | MGLN | MAGELLAN HEALTH IN ... | Lewis Clapper Caskie | Chief Human Resourc ... | Buy | X | 60.39 | 29,239 | 1,765,743 | 77,713 | 48.5 K to 77.7 K (+60.32 %) |
| Dec 05 2017 | MGLN | MAGELLAN HEALTH IN ... | Lewis Clapper Caskie | Chief Human Resourc ... | Buy | X | 53.00 | 30,074 | 1,593,922 | 48,474 | 18.4 K to 48.5 K (+163.45 %) |
| Dec 04 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 64.87 | 5,042 | 327,075 | 10,083 | |
| Dec 04 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 63.95 | 3,233 | 206,750 | 12,538 | |
| Dec 04 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 89.08 | 8,275 | 737,137 | 13,457 | 21.7 K to 13.5 K (-38.08 %) |
| Dec 04 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 64.87 | 5,042 | 327,075 | 21,732 | 16.7 K to 21.7 K (+30.21 %) |
| Dec 04 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 63.95 | 3,233 | 206,750 | 16,690 | 13.5 K to 16.7 K (+24.02 %) |
| Nov 20 2017 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,420 | 0 | 2,420 | |
| Nov 20 2017 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,420 | 0 | 4,840 | |
| Nov 20 2017 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Payment of Exercise | F | 84.75 | 1,184 | 100,344 | 26,447 | 27.6 K to 26.4 K (-4.29 %) |
| Nov 20 2017 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Buy | M | 0.00 | 2,420 | 0 | 27,631 | 25.2 K to 27.6 K (+9.60 %) |
| Nov 20 2017 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Payment of Exercise | F | 50.55 | 831 | 42,007 | 25,211 | 26 K to 25.2 K (-3.19 %) |
| Nov 20 2017 | MGLN | MAGELLAN HEALTH IN ... | Rubin Jonathan N | Chief Financial Off ... | Buy | M | 0.00 | 2,420 | 0 | 26,042 | 23.6 K to 26 K (+10.24 %) |
| Nov 07 2017 | MGLN | MAGELLAN HEALTH IN ... | SMITH BARRY M | Chief Executive Off ... | Gift | G | 0.00 | 3,000 | 0 | 29,432 | 32.4 K to 29.4 K (-9.25 %) |
| Nov 02 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 63.95 | 9,369 | 599,148 | 15,771 | |
| Nov 02 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 89.20 | 9,369 | 835,751 | 13,457 | 22.8 K to 13.5 K (-41.05 %) |
| Nov 02 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 63.95 | 9,369 | 599,148 | 22,826 | 13.5 K to 22.8 K (+69.62 %) |
| Nov 02 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 71.00 | 1,154 | 81,934 | 3,846 | |
| Nov 02 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 92.00 | 1,154 | 106,168 | 0 | 1.2 K to 0 (-100.00 %) |
| Nov 02 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 71.00 | 1,154 | 81,934 | 1,154 | 0 to 1.2 K |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 63.95 | 7,475 | 478,026 | 25,140 | |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 63.95 | 5,000 | 319,750 | 32,615 | |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 88.10 | 2,475 | 218,048 | 13,457 | 15.9 K to 13.5 K (-15.53 %) |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 88.00 | 5,000 | 440,000 | 15,932 | 20.9 K to 15.9 K (-23.89 %) |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 63.95 | 7,475 | 478,026 | 20,932 | 13.5 K to 20.9 K (+55.55 %) |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 88.00 | 5,000 | 440,000 | 13,457 | 18.5 K to 13.5 K (-27.09 %) |
| Oct 05 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 63.95 | 5,000 | 319,750 | 18,457 | 13.5 K to 18.5 K (+37.16 %) |
| Oct 04 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 53.00 | 14,420 | 764,260 | 0 | |
| Oct 04 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 47.46 | 15,601 | 740,423 | 0 | |
| Oct 04 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Sell | S | 87.31 | 30,021 | 2,621,242 | 13,931 | 44 K to 13.9 K (-68.30 %) |
| Oct 04 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 53.00 | 14,420 | 764,260 | 43,952 | 29.5 K to 44 K (+48.83 %) |
| Oct 04 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 47.46 | 15,601 | 740,423 | 29,532 | 13.9 K to 29.5 K (+111.99 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 53.00 | 2,950 | 156,350 | 14,420 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 47.46 | 3,026 | 143,614 | 15,601 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 49.10 | 13,031 | 639,822 | 0 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Sell | S | 86.22 | 19,007 | 1,638,689 | 13,931 | 32.9 K to 13.9 K (-57.71 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 53.00 | 2,950 | 156,350 | 32,938 | 30 K to 32.9 K (+9.84 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 47.46 | 3,026 | 143,614 | 29,988 | 27 K to 30 K (+11.22 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 49.10 | 13,031 | 639,822 | 26,962 | 13.9 K to 27 K (+93.54 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 53.00 | 1,038 | 55,014 | 17,370 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 47.46 | 1,009 | 47,887 | 18,627 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 49.10 | 1,000 | 49,100 | 13,031 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 42.75 | 15,464 | 661,086 | 0 | |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Sell | S | 86.18 | 18,511 | 1,595,317 | 13,931 | 32.4 K to 13.9 K (-57.06 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 53.00 | 1,038 | 55,014 | 32,442 | 31.4 K to 32.4 K (+3.31 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 47.46 | 1,009 | 47,887 | 31,404 | 30.4 K to 31.4 K (+3.32 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 49.10 | 1,000 | 49,100 | 30,395 | 29.4 K to 30.4 K (+3.40 %) |
| Oct 03 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 42.75 | 15,464 | 661,086 | 29,395 | 13.9 K to 29.4 K (+111.00 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 53.00 | 2,501 | 132,553 | 18,408 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 47.46 | 2,501 | 118,697 | 19,636 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 49.10 | 2,501 | 122,799 | 14,031 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 42.75 | 2,501 | 106,918 | 15,464 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 32.91 | 15,312 | 503,918 | 0 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Sell | S | 85.85 | 25,316 | 2,173,452 | 13,931 | 39.2 K to 13.9 K (-64.50 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 53.00 | 2,501 | 132,553 | 39,247 | 36.7 K to 39.2 K (+6.81 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 47.46 | 2,501 | 118,697 | 36,745 | 34.2 K to 36.7 K (+7.30 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 49.10 | 2,501 | 122,799 | 34,245 | 31.7 K to 34.2 K (+7.88 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 42.75 | 2,501 | 106,918 | 31,744 | 29.2 K to 31.7 K (+8.55 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 32.91 | 15,312 | 503,918 | 29,243 | 13.9 K to 29.2 K (+109.91 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 53.00 | 3,574 | 189,422 | 20,909 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 47.46 | 3,575 | 169,670 | 22,137 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 49.10 | 3,654 | 179,411 | 16,532 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 42.75 | 3,538 | 151,250 | 17,965 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Option Exercise | X | 32.91 | 5,580 | 183,638 | 15,312 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Sell | S | 86.06 | 1,419 | 122,125 | 13,931 | 15.4 K to 13.9 K (-9.24 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Sell | S | 85.24 | 18,502 | 1,577,131 | 15,350 | 33.9 K to 15.4 K (-54.66 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 53.00 | 3,574 | 189,422 | 33,852 | 30.3 K to 33.9 K (+11.80 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 47.46 | 3,575 | 169,670 | 30,278 | 26.7 K to 30.3 K (+13.39 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 49.10 | 3,654 | 179,411 | 26,703 | 23 K to 26.7 K (+15.85 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 42.75 | 3,538 | 151,250 | 23,049 | 19.5 K to 23 K (+18.13 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | WEST JEFFREY N | SVP & Controller | Buy | X | 32.91 | 5,580 | 183,638 | 19,511 | 13.9 K to 19.5 K (+40.05 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 4,848 | 293,546 | 16,666 | |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 85.76 | 4,848 | 415,782 | 0 | 4.8 K to 0 (-100.00 %) |
| Sep 29 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 4,848 | 293,546 | 4,848 | 0 to 4.8 K |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 64.87 | 7,307 | 474,005 | 14,613 | |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 11,819 | 715,640 | 21,514 | |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 86.06 | 600 | 51,635 | 0 | 600 to 0 (-100.00 %) |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 85.31 | 18,526 | 1,580,373 | 600 | 19.1 K to 600 (-96.86 %) |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 64.87 | 7,307 | 474,005 | 19,126 | 11.8 K to 19.1 K (+61.82 %) |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 11,819 | 715,640 | 11,819 | 0 to 11.8 K |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 60.39 | 35,658 | 2,153,387 | 0 | |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 85.17 | 35,658 | 3,036,928 | 13,457 | 49.1 K to 13.5 K (-72.60 %) |
| Sep 28 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 60.39 | 35,658 | 2,153,387 | 49,115 | 13.5 K to 49.1 K (+264.98 %) |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 63.95 | 2,961 | 189,356 | 1,480 | |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 84.00 | 2,961 | 248,724 | 0 | 3 K to 0 (-100.00 %) |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 63.95 | 2,961 | 189,356 | 2,961 | 0 to 3 K |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 53.00 | 2,402 | 127,306 | 0 | |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 53.00 | 18,063 | 957,339 | 2,402 | |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 83.00 | 2,402 | 199,366 | 13,457 | 15.9 K to 13.5 K (-15.15 %) |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 53.00 | 2,402 | 127,306 | 15,859 | 13.5 K to 15.9 K (+17.85 %) |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 83.05 | 18,063 | 1,500,163 | 13,457 | 31.5 K to 13.5 K (-57.31 %) |
| Sep 18 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 53.00 | 18,063 | 957,339 | 31,520 | 13.5 K to 31.5 K (+134.23 %) |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 585 | 35,422 | 40,426 | |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 19 | 1,150 | 41,011 | |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 83.00 | 585 | 48,555 | 0 | 585 to 0 (-100.00 %) |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 585 | 35,422 | 585 | 0 to 585 |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 83.00 | 19 | 1,577 | 0 | 19 to 0 (-100.00 %) |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 19 | 1,150 | 19 | 0 to 19 |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 53.00 | 14,096 | 747,088 | 20,465 | |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 83.06 | 14,096 | 1,170,883 | 13,457 | 27.6 K to 13.5 K (-51.16 %) |
| Sep 14 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 53.00 | 14,096 | 747,088 | 27,553 | 13.5 K to 27.6 K (+104.75 %) |
| Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 670 | 40,569 | 41,030 | |
| Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 83.00 | 670 | 55,610 | 0 | 670 to 0 (-100.00 %) |
| Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 670 | 40,569 | 670 | 0 to 670 |
| Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Option Exercise | X | 53.00 | 2,400 | 127,200 | 34,561 | |
| Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Sell | S | 83.00 | 2,400 | 199,200 | 13,457 | 15.9 K to 13.5 K (-15.14 %) |
| Sep 12 2017 | MGLN | MAGELLAN HEALTH IN ... | GREGOIRE DANIEL N | General Counsel and ... | Buy | X | 53.00 | 2,400 | 127,200 | 15,857 | 13.5 K to 15.9 K (+17.83 %) |
| Sep 11 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 6,267 | 379,467 | 41,700 | |
| Sep 11 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 81.53 | 6,267 | 510,918 | 0 | 6.3 K to 0 (-100.00 %) |
| Sep 11 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 6,267 | 379,467 | 6,267 | 0 to 6.3 K |
| Sep 08 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 1,033 | 62,548 | 47,967 | |
| Sep 08 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 60.55 | 1,000 | 60,550 | 49,000 | |
| Sep 08 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Option Exercise | X | 53.00 | 157 | 8,321 | 0 | |
| Sep 08 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Sell | S | 81.19 | 1,033 | 83,870 | 0 | 1 K to 0 (-100.00 %) |
| Sep 08 2017 | MGLN | MAGELLAN HEALTH IN ... | Kamal Mostafa | CEO, Magellan Rx Ma ... | Buy | X | 60.55 | 1,033 | 62,548 | 1,033 | 0 to 1 K |